IT7868355A0 - Carbostiril derivati particolarmente utili in medicina e procedimento per la loro preparazione - Google Patents

Carbostiril derivati particolarmente utili in medicina e procedimento per la loro preparazione

Info

Publication number
IT7868355A0
IT7868355A0 IT7868355A IT6835578A IT7868355A0 IT 7868355 A0 IT7868355 A0 IT 7868355A0 IT 7868355 A IT7868355 A IT 7868355A IT 6835578 A IT6835578 A IT 6835578A IT 7868355 A0 IT7868355 A0 IT 7868355A0
Authority
IT
Italy
Prior art keywords
carbostiril
medicine
procedure
preparation
particularly useful
Prior art date
Application number
IT7868355A
Other languages
English (en)
Other versions
IT1108326B (it
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of IT7868355A0 publication Critical patent/IT7868355A0/it
Application granted granted Critical
Publication of IT1108326B publication Critical patent/IT1108326B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
IT68355/78A 1977-06-10 1978-06-09 Carbostiril derivati particolarmente utili in medicina e procedimento per la loro preparazione IT1108326B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
IT7868355A0 true IT7868355A0 (it) 1978-06-09
IT1108326B IT1108326B (it) 1985-12-09

Family

ID=27284068

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68355/78A IT1108326B (it) 1977-06-10 1978-06-09 Carbostiril derivati particolarmente utili in medicina e procedimento per la loro preparazione

Country Status (21)

Country Link
US (1) US4298739A (it)
AR (2) AR224345A1 (it)
AT (1) AT367038B (it)
AU (1) AU510138B2 (it)
CA (1) CA1098907A (it)
CH (1) CH636087A5 (it)
DE (1) DE2825048A1 (it)
DK (1) DK149449C (it)
ES (2) ES470690A1 (it)
FI (1) FI69300C (it)
FR (1) FR2393795B1 (it)
GB (1) GB2002745B (it)
IE (1) IE46852B1 (it)
IT (1) IT1108326B (it)
MX (1) MX5527E (it)
NL (1) NL178074C (it)
NO (1) NO148813C (it)
NZ (1) NZ187452A (it)
PH (1) PH14670A (it)
PT (1) PT68157A (it)
SE (1) SE444562B (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
JPS60193991A (ja) * 1984-02-15 1985-10-02 シンテツクス(ユー・エス・エイ)インコーポレイテツド イミダゾキナゾリニルオキシアルキルアミド誘導体
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
TW201305B (it) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
US5506239A (en) * 1991-08-23 1996-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelets aggregation inhibitory agent
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2196453A1 (en) * 2008-12-10 2010-06-16 Cellvir Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
KR20120065360A (ko) 2009-08-21 2012-06-20 오츠카 세이야쿠 가부시키가이샤 벤조[b][1,4]디아제핀-2,4-디온 화합물의 제조 방법
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (it) * 1972-12-14 1977-10-03
JPS5234629B2 (it) * 1973-02-03 1977-09-05
NL179275C (nl) * 1973-10-24 1986-08-18 Otsuka Pharma Co Ltd Werkwijze voor de bereiding van farmacologisch werkzame glycerol-derivaten en werkwijze voor de bereiding van preparaten die ze bevatten.
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
AU3686678A (en) 1979-12-13
NZ187452A (en) 1980-05-27
GB2002745A (en) 1979-02-28
NL7806245A (nl) 1978-12-12
AR225755A1 (es) 1982-04-30
PT68157A (en) 1978-07-01
DK254878A (da) 1979-02-09
CA1098907A (en) 1981-04-07
PH14670A (en) 1981-10-30
NO782022L (no) 1978-12-12
FR2393795A1 (fr) 1979-01-05
IE46852B1 (en) 1983-10-05
CH636087A5 (de) 1983-05-13
IE781104L (en) 1978-12-10
NO148813C (no) 1983-12-21
SE7806710L (sv) 1978-12-11
DE2825048C2 (it) 1991-05-08
AU510138B2 (en) 1980-06-12
ATA421378A (de) 1981-10-15
ES479138A1 (es) 1979-07-01
DE2825048A1 (de) 1978-12-14
DK149449B (da) 1986-06-16
AR224345A1 (es) 1981-11-30
IT1108326B (it) 1985-12-09
NL178074C (nl) 1986-01-16
FR2393795B1 (fr) 1986-07-25
DK149449C (da) 1986-11-24
NO148813B (no) 1983-09-12
GB2002745B (en) 1982-02-17
FI69300B (fi) 1985-09-30
SE444562B (sv) 1986-04-21
FI781811A (fi) 1978-12-11
FI69300C (fi) 1986-01-10
US4298739A (en) 1981-11-03
AT367038B (de) 1982-05-25
ES470690A1 (es) 1979-10-16
MX5527E (es) 1983-09-23

Similar Documents

Publication Publication Date Title
IT1108326B (it) Carbostiril derivati particolarmente utili in medicina e procedimento per la loro preparazione
IT7967674A0 (it) Derivati carbostirilici e procedimento per la loro preparazione
IT1160853B (it) Derivati di feniletanolammina,particolarmente utili in terapia,e procedimento per la loro preparazione
IT1141057B (it) Derivati di deformiltilosina e loro preparazione
IT8068036A0 (it) Derivati chinonici particolarmente utili come medicamenti e procedimento per la loro preparazione
IT1106176B (it) Derivati di pirrolo loro procedimento di preparazione e loro applicazione terapeutica
IT1123120B (it) Cefem derivati e procedimento per la loro preparazione
IT1164735B (it) Derivati adenosinici e procedimento per la loro preparazione
IT1085862B (it) Nuovi derivati indolizinici e procedimento per la loro preparazione
IT7849859A0 (it) Derivati di 2-benzoil-4-cloro-glici nanilidi sostituite loro procedimento di preparazione e loro applicazione terapeutica
IT1188970B (it) Derivati della moranolina e procedimento per la loro preparazione
IT1102816B (it) Derivati amminoalcossifinilici e procedimento per la loro preparazione
IT1121483B (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1129933B (it) Derivati tioetilammidici loro composizioni farmaceutiche e procedimento per la loro preparazione
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
IT8067888A0 (it) Carbostiril derivati particolarmente utili come medicamenti e procedimento per la loro preparazione
IT1109400B (it) Derivati di 2-amminometil-fenolo e procedimento per la loro preparazione
IT1083160B (it) Derivati pectinici e procedimento per la loro preparazione
IT1113203B (it) Derivati steroideo-spiro-ossazolidinonici sostituiti e procedimento per la loro preparazione
IT7819332A0 (it) Derivati solfonilidrazonici eprocedimento per la loro preparazione.
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1106130B (it) Derivati di 24-deidrovitamina d3 e loro preparazione
IT1094864B (it) Derivati della bromexina e procedimento per la loro preparazione
IT7967037A0 (it) Derivati delle 3 alcossicarbonildiazepine particolarmente utili in terapia e procedimento per la loro preparazione